Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Mitterhauser

Showing results (161-170 of 207) with videos related to

Pageof 21
Sort By:
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and TrendsClaus Zippel, Johannes Ermert, Marianne Patt, et al.
Biological Psychiatry|September 19, 2006
Reduced serotonin-1A receptor binding in social anxiety disorderRupert R Lanzenberger, Markus Mitterhauser, Christoph Spindelegger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2017
Association Between Osteogenesis and Inflammation During the Progression of Calcified Plaque Evaluated by <sup>18</sup>F-Fluoride and <sup>18</sup>F-FDGXiang Li, Daniel Heber, Jacobo Cal-Gonzalez, et al.
Plos One|July 19, 2017
Multiparametric [11C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancerStephan H Polanec, Piotr Andrzejewski, Pascal A T Baltzer, et al.
Pharmaceutics|November 25, 2023
Synthesis and Preclinical Evaluation of Radiolabeled [<sup>103</sup>Ru]BOLD-100Barbara Happl, Marie Brandt, Theresa Balber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2018
Response assessment using <sup>68</sup>Ga-PSMA ligand PET in patients undergoing <sup>177</sup>Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancerBernhard Grubmüller, Daniela Senn, Gero Kramer, et al.
Current Oncology (Toronto, Ont.)|September 30, 2021
Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate CancerTim Wollenweber, Lucia Zisser, Elisabeth Kretschmer-Chott, et al.
Brain Structure & Function|November 15, 2017
Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivityAndreas Hahn, Gregor Gryglewski, Lukas Nics, et al.
Nuclear Medicine and Biology|May 8, 2010
[18F]FE@SUPPY and [18F]FE@SUPPY:2--metabolic considerationsDaniela Haeusler, Lukas Nics, Leonhard-Key Mien, et al.
Pageof 21

Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
Journal of Hepatology|February 18, 2014
Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive ratsPhilipp Schwabl, Berit A Payer, Jelena Grahovac, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and TrendsClaus Zippel, Johannes Ermert, Marianne Patt, et al.
Biological Psychiatry|September 19, 2006
Reduced serotonin-1A receptor binding in social anxiety disorderRupert R Lanzenberger, Markus Mitterhauser, Christoph Spindelegger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2017
Association Between Osteogenesis and Inflammation During the Progression of Calcified Plaque Evaluated by <sup>18</sup>F-Fluoride and <sup>18</sup>F-FDGXiang Li, Daniel Heber, Jacobo Cal-Gonzalez, et al.
Plos One|July 19, 2017
Multiparametric [11C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancerStephan H Polanec, Piotr Andrzejewski, Pascal A T Baltzer, et al.
Pharmaceutics|November 25, 2023
Synthesis and Preclinical Evaluation of Radiolabeled [<sup>103</sup>Ru]BOLD-100Barbara Happl, Marie Brandt, Theresa Balber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 21, 2018
Response assessment using <sup>68</sup>Ga-PSMA ligand PET in patients undergoing <sup>177</sup>Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancerBernhard Grubmüller, Daniela Senn, Gero Kramer, et al.
Current Oncology (Toronto, Ont.)|September 30, 2021
Renal and Salivary Gland Functions after Three Cycles of PSMA-617 Therapy Every Four Weeks in Patients with Metastatic Castration-Resistant Prostate CancerTim Wollenweber, Lucia Zisser, Elisabeth Kretschmer-Chott, et al.
Brain Structure & Function|November 15, 2017
Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivityAndreas Hahn, Gregor Gryglewski, Lukas Nics, et al.
Nuclear Medicine and Biology|May 8, 2010
[18F]FE@SUPPY and [18F]FE@SUPPY:2--metabolic considerationsDaniela Haeusler, Lukas Nics, Leonhard-Key Mien, et al.
Pageof 21